Medtronic CoreValve System Receives FDA Approval For Transcatheter Valve-In-Valve Procedures
Medtronic plc recently announced the U.S. Food and Drug Administration (FDA) approval of the CoreValve System for valve-in-valve (VIV) procedures in patients whose surgical aortic heart valves have failed.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news
More News: Cardiology | Food and Drug Administration (FDA) | Heart | Heart Valve Disease | Heart Valves | Medical Devices